Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

被引:18
|
作者
Zhu, Cheng-Gang [1 ]
Zhang, Yan [1 ]
Xu, Rui-Xia [1 ]
Li, Sha [1 ]
Wu, Na-Qiong [1 ]
Guo, Yuan-Lin [1 ]
Sun, Jing [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Div Dyslipidemia, State Key Lab Cardiovasc Dis,FuWai Hosp,Natl Ctr, Beijing 100037, Peoples R China
基金
北京市自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Coronary artery disease; Non-HDL-C; LDL-C; Lipoprotein subfraction; ISCHEMIC-HEART-DISEASE; SMALL DENSE LDL; CARDIOVASCULAR-DISEASE; REMNANT CHOLESTEROL; PCSK9; LEVELS; RISK-FACTOR; ASSOCIATION; MANAGEMENT; RECOMMENDATIONS; DYSLIPIDEMIA;
D O I
10.1016/j.jacl.2015.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Conflicting results have been yielded as to whether low-density lipoprotein (LDL) cholesterol (LDL-C) or non-high-density lipoprotein (HDL) cholesterol (non-HDL-C) is a better marker of coronary artery disease (CAD) risk. Recently, plasma LDL and HDL subfractions have been suggested to be more accurately reflecting the lipoproteins' atherogenicity. OBJECTIVE: We sought to compare the relationship between LDL-C or non-HDL-C and lipoprotein subfractions. METHODS: We conducted a cross-sectional study in 351 consecutive stable CAD patients without lipid-lowering therapy. The LDL and HDL separations were performed using the Lipoprint System. The LDL-C levels were measured directly, and the non-HDL-C levels were calculated. RESULTS: The cholesterol concentrations of LDL (large, medium, and small) and HDL (small) particles were increased (all P < .001) by non-HDL-C or LDL-C quartiles, whereas the mean LDL particle size and cholesterol concentrations of HDL (large) were decreased (both P < .001) by non-HDL-C quartiles. In age- and gender-adjusted analysis, the cholesterol in small LDL was much strongly related to non-HDL-C than to LDL-C (r = 0.539 vs 0.397, both P < .001). Meanwhile, the mean LDL particle size was more closely associated with non-HDL-C than LDL-C (r = -0.336 vs r = -0.136, both P < .05). Significantly, the cholesterol in large HDL was negatively correlated with non-HDL-C (r = -0223, P < .001) but not with LDL-C. These correlations were further confirmed by the fully adjusted multivariable linear regression analysis. CONCLUSIONS: Non-HDL-C, in comparison to LDL-C, was more relevant to atherogenic lipoprotein subfractions in patients with stable CAD, supporting that it may be better in assessing cardiovascular risk. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [21] Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should We Reach Beyond LDL-C?
    Toth, Peter P.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (04) : 376 - 378
  • [22] Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome
    Péter Koncsos
    Péter Fülöp
    Imre Juhász
    Klára Bíró
    László Márk
    Gábor Simonyi
    György Paragh
    Wiener klinische Wochenschrift, 2016, 128 : 858 - 863
  • [23] Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome
    Koncsos, Peter
    Fulop, Peter
    Juhasz, Imre
    Biro, Klara
    Mark, Laszlo
    Simonyi, Gabor
    Paragh, Gyorgy
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (23-24) : 858 - 863
  • [24] ALTERATIONS OF TRIGLYCERIDE, HDL-C AND NON-HDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Koncsos, P.
    Fueloep, P.
    Juhasz, I.
    Biro, K.
    Mark, L.
    Simonyi, G.
    Paragh, G. Y.
    ATHEROSCLEROSIS, 2015, 241 (01) : E135 - E135
  • [25] The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients
    Ma, Lijie
    Sun, Fang
    Zhu, Kaiyi
    Han, Qiuxia
    Sun, Qianmei
    CLINICAL INTERVENTIONS IN AGING, 2024, 19 : 1235 - 1245
  • [26] Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C
    Pencina, Michael J.
    D'Agostino, Ralph B.
    Zdrojewski, Tomasz
    Williams, Ken
    Thanassoulis, George
    Furberg, Curt D.
    Peterson, Eric D.
    Vasan, Ramachandran S.
    Sniderman, Allan D.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (10) : 1321 - 1327
  • [27] HDL-C Levels and Revascularization Procedures in Coronary Heart Disease Patients Treated With Statins to Target LDL-C Levels
    Elis, Avishay
    Pereg, David
    Froom, Paul
    Lishner, Michael
    Segev, David
    Hermoni, Doron
    CLINICAL CARDIOLOGY, 2011, 34 (09) : 572 - 576
  • [28] Non-HDL-C Is More Accurate Than LDL-C in Identifying Cardiovascular Risk and Is a Significant Therapeutic Target for Treating Dyslipidemia
    Rodriguez, Cynthia G.
    Sink, John, II
    Jacobson, Terry A.
    JOURNAL OF CARDIOVASCULAR NURSING, 2010, 25 (05) : 362 - 362
  • [29] Effects of switching statins on non-HDL-C in hypercholesterolaemic patients and achievement of ATP III combined LDL-C and non-HDL-C goals in patients with elevated triglycerides: Mercury I trial results
    Barter, P
    Stender, S
    Morrell, J
    Caplan, R
    Blasetto, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 106 - 106